Long‐term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long‐term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis
Authors
Keywords
-
Journal
JOURNAL OF DERMATOLOGY
Volume 47, Issue 2, Pages 114-120
Publisher
Wiley
Online
2019-12-10
DOI
10.1111/1346-8138.15173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study
- (2018) H. Nakagawa et al. BRITISH JOURNAL OF DERMATOLOGY
- Multipolarity of cytokine axes in the pathogenesis of atopic dermatitis in terms of age, race, species, disease stage and biomarkers
- (2018) Takashi Nomura et al. INTERNATIONAL IMMUNOLOGY
- IL-31: A new key player in dermatology and beyond
- (2018) Işın Sinem Bağci et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Phase 1 studies to assess the safety, tolerability and pharmacokinetics of JTE-052 (a novel Janus kinase inhibitor) ointment in Japanese healthy volunteers and patients with atopic dermatitis
- (2018) Hidemi Nakagawa et al. JOURNAL OF DERMATOLOGY
- A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents
- (2017) Atsuo Tanimoto et al. EXPERIMENTAL DERMATOLOGY
- Japanese guidelines for atopic dermatitis 2017
- (2017) Ichiro Katayama et al. ALLERGOLOGY INTERNATIONAL
- Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016
- (2016) Hidehisa Saeki et al. JOURNAL OF DERMATOLOGY
- 518 The effect of janus kinase inhibitor on pruritus in an atopic dermatitis murine model
- (2016) Y. Yamamoto et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling
- (2015) Wataru Amano et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo
- (2014) Atsuo Tanimoto et al. INFLAMMATION RESEARCH
- Guidelines of care for the management of atopic dermatitis
- (2014) Lawrence F. Eichenfield et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Present state of Japanese cedar pollinosis: The national affliction
- (2013) Takechiyo Yamada et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
- (2012) John J. O'Shea et al. IMMUNITY
- Functions of thymic stromal lymphopoietin in immunity and disease
- (2012) Yanlu Zhang et al. IMMUNOLOGIC RESEARCH
- Filaggrin Mutations Associated with Skin and Allergic Diseases
- (2011) Alan D. Irvine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine modulation of atopic dermatitis filaggrin skin expression
- (2009) Michael D. Howell et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started